HDAC9-IN-1

Produktübersicht

• Artikelname: HDAC9-IN-1
• Artikelnummer: MCE-HY-169259
• Hersteller Artikelnummer: HY-169259
• Alternativnummer: MCE-HY-169259-25MG,MCE-HY-169259-100MG,MCE-HY-169259-50MG,MCE-HY-169259-5MG,MCE-HY-169259-10MG,MCE-HY-169259-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

HDAC9-IN-1 is a selective class IIa HDAC inhibitor that binds to HDAC9 with an IC50 of 40 nM. HDAC9-IN-1 potently inhibits HDACs 4 and 7 while showing weak activity against HDAC6 (IC50 values: 180 nM (HDAC4), 190 nM (HDAC7), 970 nM (HDAC6)). HDAC9-IN-1 significantly inhibits several human cancer cells, induces apoptosis and DNA damage in human cancer cells, and modulates caspase-related proteins and p38 in human cancer cells. HDAC9-IN-1 can be used for the research of oral cancer, breast cancer, gastric cancer[1].

Produkteigenschaften

• Molekulargewicht: 482.55
• Reinheit: 95.13
• Formel: C27H22N4O3S
• Target-Kategorie: Apoptosis,Caspase,DNA/RNA Synthesis,HDAC,p38 MAPK,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound